The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Microbiotica Raises $48 Million Series C to Advance Pipeline into Phase 2 Clinical Development• Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health•

Category: GMO & Synbio

Smart skin bacteria are able to secrete and produce molecules to treat acne
GMO & Synbio

Smart skin bacteria are able to secrete and produce molecules to treat acne

JAN 11, 2024
Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors
Biotics and Supplements

Engineered bacteria guide CAR-T cells to poorly infiltrated solid tumors

NOV 6, 2023
Engineered probiotic developed to treat multiple sclerosis
Biotics and Supplements

Engineered probiotic developed to treat multiple sclerosis

AUG 14, 2023
Ilya Pharma’s genetically modified lactic acid bacteria drug candidate effectively accelerates wound healing in clinical study
GMO & Synbio

Ilya Pharma’s genetically modified lactic acid bacteria drug candidate effectively accelerates wound healing in clinical study

JUN 1, 2023
SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology
Finance

SNIPR Biome’s data on drug candidate to prevent infections in hematological cancer patients published in Nature Biotechnology

MAY 8, 2023
Researchers create virus-resistant, safely restrained E. coli
Editor's Choice

Researchers create virus-resistant, safely restrained E. coli

APR 10, 2023
Aurealis therapeutics raises $10 million in an oversubscribed series A financing
Finance

Aurealis therapeutics raises $10 million in an oversubscribed series A financing

APR 3, 2023
Engineered bacteria find tumors, then alert the authorities
GMO & Synbio

Engineered bacteria find tumors, then alert the authorities

MAR 13, 2023
Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders
Finance

Key patent issued on Eligo’s gene editing breakthroughs applied to skin disorders

NOV 16, 2022
Protecting the human intestinal microbiome with synthetic biology
Gastrointestinal

Protecting the human intestinal microbiome with synthetic biology

APR 18, 2022
A new photoactive viral vector for anti-cancer therapy has been developed
GMO & Synbio

A new photoactive viral vector for anti-cancer therapy has been developed

MAR 15, 2022